195 related articles for article (PubMed ID: 8249896)
1. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
Miura K; Shirasawa H
Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
[TBL] [Abstract][Full Text] [Related]
2. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
Kitajima Y; Hirata H; Kagawa Y; Yaoita H
J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
[TBL] [Abstract][Full Text] [Related]
3. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
4. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
5. AL 612, a glycosylated lambda light chain of subgroup I.
Nilsen T; Sletten K; Westermark P
Amyloid; 2000 Mar; 7(1):51-3. PubMed ID: 10842706
[No Abstract] [Full Text] [Related]
6. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
7. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
9. [The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].
Adam Z; Elleder M; Moulis M; Tichý M; Cervinková I; Rehák Z; Koukalová R; Fojtík Z; Hanke I; Pour L; Krejčí M; Zahradová L; Szturz P; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Mar; 58(3):241-52. PubMed ID: 22486293
[TBL] [Abstract][Full Text] [Related]
10. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
Grogg KL; Aubry MC; Vrana JA; Theis JD; Dogan A
Am J Surg Pathol; 2013 Mar; 37(3):406-12. PubMed ID: 23282974
[TBL] [Abstract][Full Text] [Related]
11. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
Cohen D; Pras M; Franklin EC; Frangione B
Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
[TBL] [Abstract][Full Text] [Related]
12. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
14. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
Linke RP; Geisel O; Mann K
Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoma and gastric amyloidosis associated with nodular pulmonary amyloidosis.
Jimenez C; Vital C; Merlio JP; Deminière C; Dupon M; de Mascarel A; Lacut JY
Ann Pathol; 1988; 8(2):155-7. PubMed ID: 3135815
[TBL] [Abstract][Full Text] [Related]
16. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
[TBL] [Abstract][Full Text] [Related]
17. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
Kuçi H; Ebert MP; Röcken C
Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
[TBL] [Abstract][Full Text] [Related]
18. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific (localized) synthesis of Ig light chain amyloid.
Hamidi Asl K; Liepnieks JJ; Nakamura M; Benson MD
J Immunol; 1999 May; 162(9):5556-60. PubMed ID: 10228037
[TBL] [Abstract][Full Text] [Related]
20. Demonstration and partial characterization of an atypical protein in the urine of a patient with primary amyloidosis.
Wille LE; Olsen E; Førre O; Sletten K; Jentoft H
Acta Med Scand; 1980; 208(3):177-82. PubMed ID: 6776783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
